Skip to main content
Công ty Cổ phần Dược Hậu Giang logo

Công ty Cổ phần Dược Hậu Giang — Investor Relations & Filings

Ticker · DHG ISIN · VN000000DHG0 HSX Manufacturing
Open in API
Filings indexed 181 across all filing types
Latest filing 2026-01-30 Board/Management Inform…
Country VN Viet Nam
Listing HSX DHG

About Công ty Cổ phần Dược Hậu Giang

www.dhgpharma.com.vn

Công ty Cổ phần Dược Hậu Giang (DHG Pharma) is a leading pharmaceutical enterprise with over 50 years of experience. The company specializes in the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products, including both supportive and treatment medications. DHG Pharma emphasizes the application of high technology and international production standards to ensure product quality. Key brands include Telfor, Bocalex, Natto DHA, Hapacol, and Biofermin, serving a broad consumer base. Committed to public health, DHG Pharma actively engages in community health initiatives and strives to provide high-quality, accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
DHG: Thông báo thay đổi nhân sự
Board/Management Information Classification · 98% confidence The document is a corporate announcement titled “THÔNG BÁO THAY ĐỔI NHÂN SỰ” (Change in Personnel) issued by DHG Pharmaceutical JSC pursuant to a Board of Directors resolution. It notifies the State Securities Commission and the Ho Chi Minh Stock Exchange of the dismissal and reassignment of a senior executive (Sales Director). This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2026-01-30 Vietnamese
DHG: Báo cáo tình hình quản trị công ty năm 2025
Governance Information Classification · 95% confidence The document is a detailed corporate governance report (“Báo cáo tình hình quản trị”) for DHG Pharma covering the company’s governance model, board of directors structure and activities, audit committee, executive management, training, related-party transactions, and insider share dealings. It does not present full financial statements (Annual or Interim Report), nor is it an announcement of a meeting result, proxy solicitation, or executive change. It aligns precisely with the “Governance Information” category, as it details internal rules, board composition, committees, and governance practices. Therefore, the correct classification is CGR.
2026-01-29 Vietnamese
DHG: Thông báo thay đổi nhân sự
Board/Management Information Classification · 95% confidence The document is a formal notification to the State Securities Commission and Ho Chi Minh Stock Exchange regarding the appointment and resignation of key corporate officers (BOD Secretary and corporate governance duties). It contains Board of Directors’ resolutions approving these management changes. This clearly falls under announcements of changes in the company’s board or senior management.
2026-01-28 Vietnamese
DHG: Giải trình KQKD quý 4/2025 so với cùng kỳ năm trước
Earnings Release Classification · 85% confidence The document is an ‘Extraordinary Information Disclosure’ providing headline Q4 2025 and full-year 2025 sales and profit figures and brief commentary on performance. It is not a full interim report (which would include complete financial statements) nor an annual report, but a summary of quarterly and annual results. Therefore it best matches an Earnings Release (initial announcement of periodical financial results). Q4 2025
2026-01-20 Vietnamese
DHG: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 32
Board/Management Information Classification · 92% confidence The document is a formal notification to the State Securities Commission and Ho Chi Minh Stock Exchange regarding a change in the company’s legal representative (acting General Director). It contains no financial statements or report publication language, but rather announces a senior management change. This clearly fits the definition for Board/Management Information (MANG).
2026-01-05 Vietnamese
DHG: Thông báo đơn từ nhiệm thành viên HĐQT nhiệm kỳ V (2024-2028)
Board/Management Information Classification · 92% confidence The document is an “Extraordinary Information Disclosure” filed with the State Securities Commission and Ho Chi Minh Stock Exchange announcing the resignation of a Board member (Mr. Toshiyuki Ishii) of DHG Pharmaceutical JSC, effective upon AGM approval. This is clearly a Board/Management Information announcement of a change in the board of directors. Therefore, it falls under the “Board/Management Information” category (MANG).
2025-12-25 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.